2021 年和 2022 年美国全国健康访谈调查，已确诊和未确诊糖尿病前期或糖尿病的成年人使用远程医疗的情况。

IF 4.4 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Preventing Chronic Disease Pub Date : 2024-11-14 DOI:10.5888/pcd21.240229

Ibrahim Zaganjor, Ryan Saelee, Stephen Onufrak, Yoshihisa Miyamoto, Alain K Koyama, Fang Xu, Kai McKeever Bullard, Meda E Pavkov

{"title":"2021 年和 2022 年美国全国健康访谈调查，已确诊和未确诊糖尿病前期或糖尿病的成年人使用远程医疗的情况。","authors":"Ibrahim Zaganjor, Ryan Saelee, Stephen Onufrak, Yoshihisa Miyamoto, Alain K Koyama, Fang Xu, Kai McKeever Bullard, Meda E Pavkov","doi":"10.5888/pcd21.240229","DOIUrl":null,"url":null,"abstract":"We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":"21 ","pages":"E90"},"PeriodicalIF":4.4000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567504/pdf/","citationCount":"0","resultStr":"{\"title\":\"Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022.\",\"authors\":\"Ibrahim Zaganjor, Ryan Saelee, Stephen Onufrak, Yoshihisa Miyamoto, Alain K Koyama, Fang Xu, Kai McKeever Bullard, Meda E Pavkov\",\"doi\":\"10.5888/pcd21.240229\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.\",\"PeriodicalId\":51273,\"journal\":{\"name\":\"Preventing Chronic Disease\",\"volume\":\"21 \",\"pages\":\"E90\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567504/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Preventing Chronic Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5888/pcd21.240229\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventing Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5888/pcd21.240229","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

摘要

我们分析了 2021 年和 2022 年全国健康访谈调查数据，以描述未确诊糖尿病前期或糖尿病、确诊糖尿病前期和确诊糖尿病的美国成年人过去 12 个月使用远程医疗的流行率。2021 年和 2022 年，在未确诊糖尿病或糖尿病前期的成年人中，远程医疗使用率分别为 34.1% 和 28.2%，在糖尿病前期成年人中分别为 47.6% 和 37.6%，在糖尿病成年人中分别为 52.8% 和 39.4%。在患有糖尿病前期或糖尿病的成年人中，远程医疗使用率因地区、城市化程度、保险状况和受教育程度的不同而存在差异。研究结果表明，远程医疗在部分糖尿病前期或糖尿病患者中的使用率可以提高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022.

We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Preventing Chronic Disease PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

6.70

自引率

3.60%

发文量

期刊介绍： Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. The mission of PCD is to promote the open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. The vision of PCD is to be the premier forum where practitioners and policy makers inform research and researchers help practitioners and policy makers more effectively improve the health of the population. Articles focus on preventing and controlling chronic diseases and conditions, promoting health, and examining the biological, behavioral, physical, and social determinants of health and their impact on quality of life, morbidity, and mortality across the life span.